16089-70-6

Basic information

• Product Name: Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide
• Synonyms: Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide
• CAS NO: 16089-70-6
• Molecular Formula: C₉H₈N₂O
• Molecular Weight: 160.17
• Mol File: 16089-70-6.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 332.6°C at 760 mmHg
• Flash Point: 155°C
• Appearance: /
• Density: 1.13g/cm³
• Vapor Pressure: 0.000144mmHg at 25°C
• Refractive Index: 1.567
• CAS DataBase Reference: Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide(16089-70-6)
• EPA Substance Registry System: Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide(16089-70-6)

Safety Data

• Hazardous Substances Data: 16089-70-6(Hazardous Substances Data)

Usage

Description

Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide, commonly known as carbetamide, is a chemical compound that functions as a herbicide. It is specifically designed to control grass and broadleaf weeds in various crops by interfering with the growth hormones of these unwanted plants.

Uses

Used in Agricultural Industry:
Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide is used as a herbicide for controlling grass and broadleaf weeds in a variety of crops. It is particularly favored for its application in rice paddies and other aquatic environments due to its low water solubility, which minimizes the risk of runoff into water sources. Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide's low toxicity to non-target organisms and minimal impact on soil microbiology make it a suitable choice for weed management in agricultural settings.
However, it is crucial to handle Benzonitrile,4-[(methylimino)methyl]-N(4)-oxide with caution, as it can pose health risks if ingested, inhaled, or if it comes into contact with the skin or eyes. Proper safety measures should be taken to ensure the safe and effective use of this herbicide in agricultural practices.

InChI:InChI=1/C9H8N2O/c1-11(12)7-9-4-2-8(6-10)3-5-9/h2-5,7H,1H3/b11-7+

Upstream product

• 79069-32-2 phenyl(phenylethynyl)iodonium tosylate 
• 75-52-5 nitromethane 
• 105-07-7 4-cyanobenzaldehyde 
• 4229-44-1 N-methylhydroxyamine hydrochloride 

Downstream Products

• 123466-44-4 3-(p-cyanophenyl)-5-phenyl-2,3-dihydroisoxazol-4-yl(phenyl)iodonium toluene-p-sulphonate 
• 105-07-7 4-cyanobenzaldehyde 
• 1385717-25-8 C₃₅H₂₈N₄O₄ 
• 1542213-01-3 C₉H₈N₂O 

Relevant articles and documents

Cooperative Multifunctional Catalysts for Nitrone Synthesis: Platinum Nanoclusters in Amine-Functionalized Metal–Organic Frameworks

Nitrones are key intermediates in organic synthesis and the pharmaceutical industry. The heterogeneous synthesis of nitrones with multifunctional catalysts is extremely attractive but rarely explored. Herein, we report ultrasmall platinum nanoclusters (PtNCs) encapsulated in amine-functionalized Zr metal–organic framework (MOF), UiO-66-NH2 (Pt@UiO-66-NH2) as a multifunctional catalyst in the one-pot tandem synthesis of nitrones. By virtue of the cooperative interplay among the selective hydrogenation activity provided by the ultrasmall PtNCs and Lewis acidity/basicity/nanoconfinement endowed by UiO-66-NH2, Pt@UiO-66-NH2 exhibits remarkable activity and selectivity, in comparison to Pt/carbon, Pt@UiO-66, and Pd@UiO-66-NH2. Pt@UiO-66-NH2 also outperforms Pt nanoparticles supported on the external surface of the same MOF (Pt/UiO-66-NH2). To our knowledge, this work demonstrates the first examples of one-pot synthesis of nitrones using recyclable multifunctional heterogeneous catalysts.

Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists

The present invention relates generally to cyclic carbamates and isoxazolidines or Formula (I) or their pharmaceutically acceptable salts thereof, which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharma

Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists

STR1 This invention relates generally to cyclic carbamates and hydroxylamines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for prepar